Clinical Trials Browser

Phase 2/3 × Locally Advanced Rectal Carcinoma × tislelizumab × Clear all

NCT06312982 2026-01-13

A Series of Neoadjuvant Chemoradiotherapy Combined With Immunotherapy for Locally Advanced Rectal Cancer

Phase 2/3 Recruiting

Gastrointestinal

Locally Advanced Rectal Carcinoma